Spravato Explained: What You Need to Know About This Innovative Depression Therapy
What is Spravato?
Spravato is the brand name for esketamine, a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treatment-resistant depression (TRD) and depressive symptoms in adults with major depressive disorder (MDD) who have suicidal thoughts or actions. Esketamine is derived from ketamine, an anesthetic that has been used for decades, but Spravato is specifically designed for its antidepressant effects.
How Does Spravato Work?
Spravato works differently from traditional antidepressants. It is a nasal spray that acts on the brain's glutamate system, specifically targeting the N-methyl-D-aspartate (NMDA) receptor. By modulating the activity of glutamate, a neurotransmitter involved in mood regulation, Spravato can rapidly improve symptoms of depression. This rapid action is beneficial compared to traditional antidepressants, which often take weeks to show effects.
Who Can Benefit From Spravato?
Spravato is primarily prescribed for adults with treatment-resistant depression, meaning those who have not responded adequately to at least two other antidepressant treatments. It is also used for adults with major depressive disorder who are experiencing acute suicidal ideation or behavior. Patients must be enrolled in the Spravato REMS (Risk Evaluation and Mitigation Strategy) program due to the potential for serious side effects, including sedation and dissociation.
Administration and Supervision
Spravato is administered under the supervision of a healthcare professional in a certified medical office or clinic. The treatment involves an initial phase with twice-weekly doses for the first four weeks, followed by a maintenance phase with less frequent dosing. Patients are monitored for at least two hours after each dose to manage any adverse effects and ensure safety.
Potential Side Effects
Common side effects of Spravato include dizziness, nausea, increased blood pressure, and a feeling of disconnection from one's thoughts, feelings, and surroundings (dissociation). Because of these potential side effects, patients are advised not to drive or operate heavy machinery until the day after receiving the treatment and only once they feel fully recovered.
Effectiveness and Considerations
Clinical trials have shown that Spravato can significantly reduce depressive symptoms in people with treatment-resistant depression (TRD) and those with major depressive disorder (MDD) experiencing suicidal thoughts. However, it is often used in conjunction with an oral antidepressant to maximize effectiveness. Patients considering Spravato should discuss their medical history and potential risks with their healthcare provider to determine if it is the right treatment option for them.
As with any medication, it is essential to weigh the benefits against the potential risks and to use Spravato under strict medical supervision. Consult with a care advocate to evaluate if Spravato is right for you and take a step towards better mental health.